DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Khalaf DJ, Sunderland K, Eigl BJ. et al.
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.
Eur Urol 2019;
75: 940-947
DOI: 10.1016/j.eururo.2018.12.015.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.